“Shot in the arm” for vaccine development

Israel’s Nasvax will receive a NIS 3.5 million grant to help finance development of its vaccines to prevent graft rejection after transplantation, and to treat Streptococcus pneumoniae, and Alzheimer’s disease.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published.